Financial Metrics
MDLN Medline Inc.Financial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 23231000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 25507000000.0 | +9.8% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 28432000000.0 | +11.5% | USD | 10-K | 2026-02-25 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 5885000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 6976000000.0 | +18.5% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 7518000000.0 | +7.8% | USD | 10-K | 2026-02-25 |
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 1250000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 2146000000.0 | +71.7% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 2212000000.0 | +3.1% | USD | 10-K | 2026-02-25 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 234000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 1163000000.0 | +397.0% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | -9000000.0 | -100.8% | USD | 10-K | 2026-02-25 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | -0.01 | — | USD/shares | 10-K | 2026-02-25 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | -0.01 | — | USD/shares | 10-K | 2026-02-25 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 199000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1939000000.0 | +874.4% | USD | 10-K | 2026-02-25 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 3219000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 3533000000.0 | +9.8% | USD | 10-K | 2026-02-25 |
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 4456000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 4769000000.0 | +7.0% | USD | 10-K | 2026-02-25 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 8272000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 10679000000.0 | +29.1% | USD | 10-K | 2026-02-25 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 35978000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 38484000000.0 | +7.0% | USD | 10-K | 2026-02-25 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 2440000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 2490000000.0 | +2.0% | USD | 10-K | 2026-02-25 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 19454000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 19198000000.0 | -1.3% | USD | 10-K | 2026-02-25 |
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | 19286000000.0 | — | USD | 10-K | 2026-02-25 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 16416000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 12484000000.0 | -24.0% | USD | 10-K | 2026-02-25 |
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 1685000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 1769000000.0 | +5.0% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 1744000000.0 | -1.4% | USD | 10-K | 2026-02-25 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | -312000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | -1493000000.0 | -378.5% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | -474000000.0 | +68.3% | USD | 10-K | 2026-02-25 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | -191000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | -1613000000.0 | -744.5% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 399000000.0 | +124.7% | USD | 10-K | 2026-02-25 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 275000000.0 | — | USD | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 354000000.0 | +28.7% | USD | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 447000000.0 | +26.3% | USD | 10-K | 2026-02-25 |
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | 809688877.0 | — | shares | 10-K | 2026-02-25 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | 809688877.0 | — | shares | 10-K | 2026-02-25 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 9Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 0.7090 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.7388 | +4.2% | ratio | 10-K | 2026-02-25 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 3.3902 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 4.2888 | +26.5% | ratio | 10-K | 2026-02-25 |
Debt to Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | 0.9954 | — | ratio | 10-K | 2026-02-25 |
Gross Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 0.2533 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.2735 | +8.0% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.2644 | -3.3% | ratio | 10-K | 2026-02-25 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 0.0101 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.0456 | +352.7% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | -0.0003 | -100.7% | ratio | 10-K | 2026-02-25 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2023-12-31 | 0.0538 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2024-12-31 | 0.0841 | +56.4% | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.0778 | -7.5% | ratio | 10-K | 2026-02-25 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 0.0816 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | 0.7787 | +854.8% | ratio | 10-K | 2026-02-25 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2024-12-31 | 0.0323 | — | ratio | 10-K | 2026-02-25 |
| Annual | 2025-12-31 | -0.0002 | -100.7% | ratio | 10-K | 2026-02-25 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2025-12-31 | -0.0005 | — | ratio | 10-K | 2026-02-25 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | HEALY PATRICK J | — |
Other acquired transaction
J
|
Class A Common Stock | 69,666 | — | — | 150,039 |
| 2026-03-10 | HEALY PATRICK J | — |
Other acquired transaction
J
|
Class A Common Stock | 507,844 | — | — | 1,208,159 |
| 2026-03-05 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A
|
Class A Common Stock | 25,788 | $0.00 | $0 | 25,788 |
| 2026-02-11 | CP Circle Holdings, L.P. | — |
Other disposed transaction
J · derivative
|
Common Units of Medline Holdings, LP | 15,369,974 | — | — | 0 |
| 2026-02-11 | CP Circle Holdings, L.P. | — |
Other disposed transaction
J
|
Class B Common Stock | 15,369,974 | — | — | 0 |
| 2026-02-11 | CP Circle Holdings, L.P. | — |
Other disposed transaction
J
|
Class A Common Stock | 2,615 | — | — | 0 |
| 2026-01-16 | TC Group VIII, L.L.C. | — |
Other disposed transaction
J
|
Class A Common Stock | 94,348,666 | — | — | 0 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Exercise / conversion
C · derivative
|
Common Units | 2,098,005 | — | — | 115,788,967 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Open-market sell
S · derivative
|
Common Units | 9,028,455 | $28.37 | $256,125,531 | 117,886,972 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Other disposed transaction
J
|
Class B Common Stock | 2,098,005 | — | — | 115,788,967 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Other disposed transaction
J
|
Class A Common Stock | 2,098,005 | — | — | 19,310 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Exercise / conversion
C
|
Class A Common Stock | 2,098,005 | — | — | 2,117,315 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Other disposed transaction
J
|
Class A Common Stock | 313,116 | — | — | 8,955,577 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Other disposed transaction
J
|
Class A Common Stock | 3,157,629 | — | — | 85,733,022 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Other disposed transaction
J
|
Class B Common Stock | 9,028,455 | — | — | 117,886,972 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Open-market sell
S
|
Class A Common Stock | 461,760 | $28.37 | $13,099,346 | 4,806,160 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Open-market sell
S
|
Class A Common Stock | 547,305 | $28.37 | $15,526,112 | 9,268,693 |
| 2025-12-18 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — |
Open-market sell
S
|
Class A Common Stock | 5,079,306 | $28.37 | $144,091,276 | 88,890,651 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A · derivative
|
Incentive Units of Medline Holdings, LP | 149,005 | — | $4,124,458 | 149,005 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A · derivative
|
Incentive Units of Medline Holdings, LP | 157,800 | — | $2,999,778 | 157,800 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A · derivative
|
Incentive Units of Medline Holdings, LP | 212,755 | — | $3,240,259 | 212,755 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A · derivative
|
Incentive Units of Medline Holdings, LP | 463,211 | — | $7,142,714 | 463,211 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A · derivative
|
Incentive Units of Medline Holdings, LP | 948,597 | — | $14,627,366 | 948,597 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A · derivative
|
Common Units of Medline Holdings, LP | 465,864 | — | — | 465,864 |
| 2025-12-16 | Golwas Douglas P | Chief Commercial Officer |
Equity grant / award
A
|
Class B Common Stock | 465,864 | — | — | 465,864 |